Shares of Silence Therapeutics SLN plunged 36.8% on Tuesday despite reporting positive end-of-treatment data from a mid-stage study of lead candidate, zerlasiran, to treat atherosclerotic ...
Silence Therapeutics plc, a biotechnology company, engages in the discovery and development of novel molecules incorporating short interfering ribonucleic acid (siRNA) to inhibit the expression of ...
We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Silence Therapeutics plc (NASDAQ:SLN) ...
Silence Therapeutics PLC ADR Annual stock financials by MarketWatch. View the latest SLN financial statements, income statements and financial ratios.
The usefulness of sentinel lymph node (SLN) biopsy was investigated among patients with melanoma and SLN metastases. Known to be effective for staging cutaneous melanoma, sentinel lymph node (SLN) ...
SLN Coffee Group has appointed Sahib Singh as the new CEO. Singh comes with an illustrious background, having carved a niche for himself during his tenure at Hindustan Unilever Limited (HUL) and ...
PARIS, Feb 13 (Reuters) - The French government has agreed to grant a 40 million euro ($42.9 million) loan to SLN, the New Caledonian nickel producer controlled by mining group Eramet ERMT.PAfacing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results